The NMPA hosts a searchable database of monographs. You can use browser translation (Chrome translate) to read the standards. This is the only free official source.
The short answer: No legal, free, complete PDF of the English translation exists for public download.
Why? The English edition is published by the Chinese Pharmacopoeia Commission (through China Pharmaceutical Science and Technology Press). It is a paid publication. Unlike the USP-NF or Ph. Eur., China does not release a public access PDF for the ChP.
Beware of Scam Sites: If you see a website offering a direct "ChP 2020 English download PDF" link, be very careful. Most are either:
Some technical libraries and university databases provide access to ChP 2020 English PDFs for members.
The direct source. You can purchase the English set directly from their website or via their authorized agents. The 2020 English edition is usually sold as a print + download bundle. chinese pharmacopoeia 2020 english download pdf
Last updated: [Current Date] – Information verified against ChPC 2024 announcements.
Disclaimer: This article is for informational purposes only. Laws and pricing regarding the Chinese Pharmacopoeia 2020 English PDF downloads are subject to change. Always consult the official Chinese Pharmacopoeia Commission or a legal advisor for regulatory compliance.
Pick one of the three and I’ll produce the long post accordingly.
The Chinese Pharmacopoeia (ChP) 2020 Edition is the 11th official compendium of drug standards for the People's Republic of China. It became effective on December 30, 2020, and the official English translation was released on March 14, 2023. It serves as a critical regulatory document for any company developing, manufacturing, or selling pharmaceuticals in the Chinese market. Official Status & Access
Official Publisher: Compiled by the Chinese Pharmacopoeia Commission (ChP Commission) under the National Medical Products Administration (NMPA). The NMPA hosts a searchable database of monographs
English Release: The authorized English version was published by China Medical Science Press in early 2023.
Format: Primarily available as a multi-volume hardback set. While some regulatory consulting firms like BaiPharm and Cisema provide access to digital versions for a fee, there is no official "free public PDF" from the Chinese government.
2025 Transition: Note that a 2025 Edition has been released and is scheduled to replace the 2020 version on October 1, 2025.
### Structure and Content OverviewThe 2020 edition contains 5,911 monographs—an increase of 319 from the 2015 edition—organized into four volumes. Focus Area Volume I Traditional Chinese Medicine (TCM) 2,711 monographs (herbs, decoction pieces, oils, etc.) Volume II Chemical Drugs 2,712 monographs (APIs and synthetic drug preparations) Volume III Biological Products 153 monographs (vaccines, blood products, etc.) Volume IV General Rules & Excipients 361 technical requirements and 335 excipient monographs Key Updates in the 2020 Edition
Safety Standards: Significantly increased requirements for testing heavy metals, pesticide residues, and mycotoxins in TCMs. Disclaimer: This article is for informational purposes only
International Alignment: Greater harmonization with ICH guidelines, including updated standards for genotoxic impurities, stability testing, and analytical method verification.
Advanced Analytics: Integration of modern technologies such as PCR, DNA sequencing, and X-ray fluorescence spectrometry for drug identification and purity.
Excipient Focus: Volume IV includes 65 new monographs for pharmaceutical excipients, aiming to improve the overall quality of finished preparations.
Chinese Pharmacopoeia 2025 Edition Implementation Announced - Cisema
Once you legally obtain the Chinese Pharmacopoeia 2020 English download PDF, efficient searching is key.